Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Cells ; 10(11)2021 11 15.
Article in English | MEDLINE | ID: mdl-34831393

ABSTRACT

Uveitis is one of the main causes of blindness worldwide, and therapeutic alternatives are worthy of study. We investigated the effects of piperlongumine (PL) and/or annexin A1 (AnxA1) mimetic peptide Ac2-26 on endotoxin-induced uveitis (EIU). Rats were inoculated with lipopolysaccharide (LPS) and intraperitoneally treated with Ac2-26 (200 µg), PL (200 and 400 µg), or Ac2-26 + PL after 15 min. Then, 24 h after LPS inoculation, leukocytes in aqueous humor, mononuclear cells, AnxA1, formyl peptide receptor (fpr)1, fpr2, and cyclooxygenase (COX)-2 were evaluated in the ocular tissues, along with inflammatory mediators in the blood and macerated supernatant. Decreased leukocyte influx, levels of inflammatory mediators, and COX-2 expression confirmed the anti-inflammatory actions of the peptide and pointed to the protective effects of PL at higher dosage. However, when PL and Ac2-26 were administered in combination, the inflammatory potential was lost. AnxA1 expression was elevated among groups treated with PL or Ac2-26 + PL but reduced after treatment with Ac2-26. Fpr2 expression was increased only in untreated EIU and Ac2-26 groups. The interaction between Ac2-26 and PL negatively affected the anti-inflammatory action of Ac2-26 or PL. We emphasize that the anti-inflammatory effects of PL can be used as a therapeutic strategy to protect against uveitis.


Subject(s)
Annexin A1/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Dioxolanes/therapeutic use , Peptides/therapeutic use , Uveitis/chemically induced , Uveitis/drug therapy , Animals , Annexin A1/administration & dosage , Annexin A1/pharmacology , Anti-Inflammatory Agents/pharmacology , Cilia/enzymology , Cilia/pathology , Cyclooxygenase 2/metabolism , Dioxolanes/administration & dosage , Dioxolanes/pharmacology , Endotoxins , Eye/drug effects , Eye/pathology , Inflammation Mediators/metabolism , Male , Models, Biological , Monocytes/drug effects , Neutrophils/drug effects , Peptides/administration & dosage , Peptides/pharmacology , Rats, Wistar , Receptors, Lipoxin/metabolism , Uveitis/blood , Uveitis/pathology
2.
Eur J Neurosci ; 26(9): 2524-31, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17970729

ABSTRACT

Olfactory sensory neurons respond to odorants increasing Ca(2+) concentrations in their chemosensory cilia. Calcium enters the cilia through cAMP-gated channels, activating Ca(2+)-dependent chloride or potassium channels. Calcium also has a fundamental role in odour adaptation, regulating cAMP turnover rate and the affinity of the cyclic nucleotide-gated channels for cAMP. It has been shown that a Na(+)/Ca(2+) exchanger (NCX) extrudes Ca(2+) from the cilia. Here we confirm previous evidence that olfactory cilia also express plasma membrane Ca(2+)-ATPase (PMCA), and show the first evidence supporting a role in Ca(2+) removal. Both transporters were detected by immunoblot of purified olfactory cilia membranes. The pump was also revealed by immunocytochemistry and immunohistochemistry. Inside-out cilia membrane vesicles transported Ca(2+) in an ATP-dependent fashion. PMCA activity was potentiated by luminal Ca(2+) (K(0.5) = 670 nm) and enhanced by calmodulin (CaM; K(0.5) = 31 nm). Both carboxyeosin (CE) and calmidazolium reduced Ca(2+) transport, as expected for a CaM-modulated PMCA. The relaxation time constant (tau) of the Ca(2+)-dependent Cl(-) current (272 +/- 78 ms), indicative of luminal Ca(2+) decline, was increased by CE (2181 +/- 437 ms), by omitting ATP (666 +/- 49 ms) and by raising pH (725 +/- 65 ms), suggesting a role of the pump on Ca(2+) clearance. Replacement of external Na(+) by Li(+) had a similar effect (tau = 442 +/- 8 ms), confirming the NCX involvement in Ca(2+) extrusion. The evidence suggests that both Ca(2+) transporters contribute to re-establish resting Ca(2+) levels in the cilia following olfactory responses.


Subject(s)
Calcium Signaling/physiology , Calcium/metabolism , Cell Membrane/enzymology , Cilia/enzymology , Olfactory Receptor Neurons/enzymology , Plasma Membrane Calcium-Transporting ATPases/metabolism , Adenosine Triphosphate/metabolism , Animals , Biological Transport, Active/drug effects , Biological Transport, Active/physiology , Bufonidae , Calcium/pharmacology , Calcium Signaling/drug effects , Calmodulin/metabolism , Calmodulin/pharmacology , Cell Membrane/drug effects , Cilia/drug effects , Enzyme Inhibitors/pharmacology , Immunohistochemistry , Olfactory Receptor Neurons/drug effects , Plasma Membrane Calcium-Transporting ATPases/drug effects , Rats , Rats, Sprague-Dawley , Smell/drug effects , Smell/physiology , Sodium-Calcium Exchanger/drug effects , Sodium-Calcium Exchanger/metabolism , Subcellular Fractions
SELECTION OF CITATIONS
SEARCH DETAIL